VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
UTI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
UTIUniversal Technical Institute, Inc.
$19.93$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUTIFinancials

Universal Technical Institute, Inc. (UTI) Income Statement

26Y historyFree accessUpdated daily

Revenue growth persists at 7.2% year-over-year in 2026Q3, but operating margin has compressed to 1.5% from 13.6% in 2025Q1, with SG&A up 15% year-over-year and SBC surging to $9.4M.

Income StatementBalance SheetCash FlowRatios

UTI Income Statement

Annual statement

UTI Income Statement

Universal Technical Institute, Inc. (UTI) annual income statement — 26-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00
Sales/Revenue883.6M835.62M732.69M607.41M418.76M335.08M300.76M331.5M316.96M324.26M347.15M362.67M378.39M380.27M413.55M451.9M435.92M366.63M343.46M353.37M347.07M310.8M255.15M196.5M144.37M109.49M92.08M
Revenue Growth %9.15%14.05%20.63%45.05%24.97%11.41%-9.27%4.59%-2.25%-6.59%-4.28%-4.15%-0.49%-8.05%-8.49%3.67%18.9%6.75%-2.8%1.82%11.67%21.81%29.85%36.1%31.86%18.91%-
Cost of Goods Sold448.67M420.49M384.53M329.87M207.23M166.82M155.93M178.32M182.59M181.03M194.4M194.42M200.05M199.54M211.98M223.47M212.58M193.49M186.64M186.25M173.23M145.03M116.73M92.44M70.81M59.55M48.52M
COGS % of Revenue-50.32%52.48%54.31%49.49%49.78%51.85%53.79%57.61%55.83%56%53.61%52.87%52.47%51.26%49.45%48.77%52.77%54.34%52.71%49.91%46.66%45.75%47.05%49.05%54.39%52.7%
Gross Profit434.93M415.13M348.16M277.54M211.53M168.26M144.83M153.19M134.38M143.24M152.75M168.26M178.34M180.73M201.57M228.43M223.34M173.15M156.82M167.13M173.84M165.77M138.42M104.05M73.56M49.94M43.56M
Gross Margin %49.22%49.68%47.52%45.69%50.51%50.22%48.15%46.21%42.39%44.17%44%46.39%47.13%47.53%48.74%50.55%51.23%47.23%45.66%47.29%50.09%53.34%54.25%52.95%50.95%45.61%47.3%
Gross Profit Growth %-19.23%25.45%31.2%25.71%16.18%-5.46%14%-6.19%-6.23%-9.22%-5.65%-1.32%-10.34%-11.76%2.28%28.99%10.41%-6.17%-3.86%4.86%19.76%33.03%41.45%47.3%14.65%-
Operating Expenses390.67M331.66M289.27M256.14M189.16M153.32M148.7M160.99M169.65M145.06M171.37M165.12M172M174.8M187.46M183.33M176.79M154.5M146.12M143.38M133.1M110M88.3M67.9M51.54M38.33M33.89M
OpEx % of Revenue-39.69%39.48%42.17%45.17%45.76%49.44%48.56%53.52%44.74%49.37%45.53%45.46%45.97%45.33%40.57%40.56%42.14%42.54%40.57%38.35%35.39%34.61%34.55%35.7%35.01%36.81%
Selling, General & Admin380.87M331.66M289.27M256.14M183.26M152.52M148.7M160.99M169.65M141.54M167.68M201.25M164.81M165.39M176.49M183.33M176.79M154.5M146.12M143.38M133.1M110M88.3M67.9M51.54M38.33M33.89M
SG&A % of Revenue-39.69%39.48%42.17%43.76%45.52%49.44%48.56%53.52%43.65%48.3%55.49%43.56%43.49%42.68%40.57%40.56%42.14%42.54%40.57%38.35%35.39%34.61%34.55%35.7%35.01%36.81%
Research & Development000000000000000000000000000
R&D % of Revenue---------------------------
Other Operating Expenses1.02M0005.9M800K0003.52M3.7M140K563K655K10.97M000000000000
Operating Income44.26M83.47M58.89M21.4M22.37M14.95M-3.87M-7.8M-35.27M-1.82M-18.62M-9.22M6.34M5.93M14.12M45.1M46.55M18.64M10.7M23.75M40.74M55.78M50.12M36.16M22.02M11.61M9.66M
Operating Margin %5.01%9.99%8.04%3.52%5.34%4.46%-1.29%-2.35%-11.13%-0.56%-5.36%-2.54%1.67%1.56%3.41%9.98%10.68%5.08%3.11%6.72%11.74%17.95%19.64%18.4%15.25%10.6%10.49%
Operating Income Growth %-41.73%175.2%-4.36%49.69%486.13%50.38%77.88%-1833.94%90.21%-101.92%-245.54%6.88%-57.99%-68.71%-3.1%149.72%74.26%-54.96%-41.7%-26.96%11.28%38.63%64.21%89.7%20.12%-
EBITDA100.42M140.25M110.08M67.22M55.15M44.58M32.21M8.1M-19.59M15.06M-874K9.93M26.81M28.09M37.93M69.95M66.44M36.21M28.3M42.5M54.95M65.56M58.93M42.54M26.97M16.14M13.55M
EBITDA Margin %11.36%16.78%15.02%11.07%13.17%13.3%10.71%2.44%-6.18%4.64%-0.25%2.74%7.09%7.39%9.17%15.48%15.24%9.88%8.24%12.03%15.83%21.09%23.1%21.65%18.68%14.74%14.72%
EBITDA Growth %-28.07%27.42%63.76%21.88%23.72%38.42%297.51%141.36%-230.04%1823.34%-108.8%-62.96%-4.54%-25.96%-45.77%5.28%83.48%27.94%-33.41%-22.65%-16.18%11.23%38.54%57.75%67.09%19.11%-
D&A (Non-Cash Add-back)56.16M56.78M51.19M45.82M32.78M29.63M36.08M15.9M15.69M16.89M17.75M19.16M20.47M22.16M23.82M24.84M19.89M17.57M17.61M18.75M14.21M9.78M8.81M6.38M4.95M4.53M3.89M
EBIT48.1M89.91M65.7M27.74M22.25M15.46M-2.58M-4.45M-32.39M650K-15.42M-8.34M6.34M6.03M15.1M45.65M47.29M19.35M10.7M23.75M40.74M55.78M50.12M36.16M22.02M11.61M9.66M
Net Interest Income704K540K-3.16M-3.79M-1.5M-282K1.14M-1.73M-1.89M-2.48M-3.2M-2.13M-1.62M234K302K252K250K198K000000000
Interest Income4.71M6.17M6.31M5.86M507K83K1.15M1.49M1.43M900K243K215K223K234K306K258K259K246K000000000
Interest Expense4.01M5.63M9.47M9.66M2M365K10K3.22M3.31M3.38M3.44M2.34M1.85M04K6K9K48K000000000
Other Income/Expense996K805K-2.66M-3.31M-1.93M236K1.28M137K-422K-907K-2.9M-1.46M-590K889K847K543K729K664K3.32M2.62M2.97M1.46M-2.17M-3.42M-7.1M-10.67M-11.88M
Pretax Income45.25M84.27M56.23M18.09M20.44M15.18M-2.59M-7.67M-35.7M-2.73M-21.53M-10.68M5.75M6.82M14.96M45.65M47.28M19.3M14.02M26.37M43.71M57.24M47.96M32.73M14.92M933K-2.21M
Pretax Margin %5.12%10.09%7.67%2.98%4.88%4.53%-0.86%-2.31%-11.26%-0.84%-6.2%-2.95%1.52%1.79%3.62%10.1%10.85%5.27%4.08%7.46%12.59%18.42%18.8%16.66%10.33%0.85%-2.4%
Income Tax10.96M21.26M14.23M5.76M-5.41M602K-10.6M203K-3.02M5.4M26.17M-1.53M3.71M3.01M5.93M18.41M18.45M7.57M5.8M10.81M16.32M21.42M19.14M12.35M5.23M10.67M34.01M
Effective Tax Rate %24.21%25.22%25.3%31.87%-26.45%3.96%408.71%-2.65%8.45%-197.62%-121.57%14.34%64.56%44.12%39.63%40.33%39.03%39.22%41.4%40.98%37.35%37.42%39.9%37.74%35.05%1143.84%-1535.95%
Net Income34.3M63.02M42M12.32M25.85M14.58M8.01M-7.87M-32.68M-8.13M-47.7M-9.15M2.04M3.81M9.03M27.24M28.83M11.73M8.22M15.56M27.39M35.82M28.82M20.38M9.69M-9.74M-36.22M
Net Margin %3.88%7.54%5.73%2.03%6.17%4.35%2.66%-2.37%-10.31%-2.51%-13.74%-2.52%0.54%1%2.18%6.03%6.61%3.2%2.39%4.4%7.89%11.52%11.3%10.37%6.71%-8.89%-39.34%
Net Income Growth %-45.65%50.04%240.86%-52.33%77.27%82.08%201.78%75.93%-302.09%82.96%-421.32%-549.14%-46.54%-57.82%-66.84%-5.52%145.7%42.81%-47.21%-43.17%-23.54%24.29%41.42%110.33%199.49%73.11%-
Net Income (Continuing)34.3M63.02M42M12.32M25.85M14.58M8.01M-7.87M-32.68M-8.13M-47.7M-9.15M2.04M3.81M9.03M26.9M28.83M11.73M8.22M15.56M27.39M35.82M28.82M20.38M9.69M-9.74M-36.22M
Discontinued Operations000000000000000000000000000
Minority Interest000000000000000000000000000
EPS (Diluted)0.611.130.750.130.380.170.05-0.52-1.51-0.54-2.02-0.380.080.150.361.101.180.480.320.570.971.261.040.790.44-0.73-2.70
EPS Growth %-45.81%50.67%476.92%-65.79%123.53%218.35%110.27%65.56%-179.63%73.27%-431.58%-575%-46.67%-58.33%-67.27%-6.78%145.83%50%-43.86%-41.24%-23.02%21.15%31.65%79.55%160.27%72.96%-
EPS (Basic)-1.160.770.130.390.170.05-0.52-1.51-0.54-2.02-0.380.080.160.371.121.200.480.320.580.991.281.141.030.51-0.73-2.70
Diluted Shares Outstanding55.94M55.62M50.85M34.48M33.74M33.12M30.11M25.44M25.11M24.71M24.31M24.39M24.92M24.7M24.94M24.74M24.51M24.63M25.81M27.42M28.25M28.54M27.59M25.05M20.24M13.4M13.43M
Basic Shares Outstanding55.08M54.3M49.43M33.98M33.22M32.77M29.81M25.44M25.11M24.71M24.31M24.08M24.64M24.52M24.71M24.43M24.04M24.25M25.57M26.77M27.8M27.9M24.66M13.54M13.4M13.4M13.43M
Dividend Payout Ratio------1.24%-----484.78%257.74%82.21%133.39%126.03%-----43.57%24.54%---

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

SBC dilution and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Momentum Persists

UTI's revenue grew 7.2% year-over-year in 2026Q3 to $218.9M, continuing a streak of double-digit growth through 2025, according to the latest quarterly report.

The company has sustained revenue growth above 12% for the past five quarters, with the most recent quarter showing a slight deceleration from the 13.3% in 2025Q4. This suggests demand for technical education remains robust, but the pace may be moderating. Investors should monitor whether growth can be maintained as the base becomes larger.

Gross Margin Volatility Raises Questions

Gross margin swung from 50.6% in 2025Q2 to 46.7% in 2026Q2, then jumped to 100% in 2026Q3 due to a data anomaly, as per financial statements.

The reported 100% gross margin in 2026Q3 appears to be a data artifact, as COGS is missing. Excluding that, gross margins have ranged between 46% and 51% over the past year, indicating some instability. This could reflect changes in program mix or cost structure, warranting further investigation into the underlying drivers.

Operating Leverage Fades

Operating income fell to $3.2M in 2026Q3 from $25.0M in 2025Q4, despite revenue growth, as SG&A expenses rose to $97.3M, per reported figures.

The operating margin contracted from 11.2% in 2025Q4 to 1.5% in 2026Q3, indicating that SG&A costs are growing faster than revenue. This suggests the company is investing heavily in sales and marketing or administrative infrastructure, which may be necessary for growth but is currently pressuring profitability. The trend may reverse if revenue growth accelerates.

SBC Dilutes Earnings

Stock-based compensation surged to $9.4M in 2026Q3, up from $2.7M a year earlier, while net income dropped to $2.3M, as disclosed in the income statement.

The significant increase in SBC, which is now nearly four times net income, suggests that reported earnings are being substantially diluted. This may indicate that a large portion of employee compensation is equity-based, which could be a concern for shareholders as it reduces EPS. The quality of earnings appears lower when SBC is excluded, and investors should adjust for this non-cash expense.

SG&A Escalation Pressures Margins

SG&A expenses climbed to $97.3M in 2026Q3, up from $84.5M in 2025Q3, representing a 15% increase, according to the latest quarterly data.

The rise in SG&A is outpacing revenue growth, which grew only 7.2% in the same period. This suggests that the company is increasing spending on marketing, admissions, or administrative support to drive enrollment, but the return on that investment is not yet evident in operating income. If this trend continues, margins could remain under pressure.

Margin Compression and Dilution Risks

Despite revenue growth, operating margin has compressed from 13.6% in 2025Q1 to 1.5% in 2026Q3, and SBC has risen sharply, per reported financials.

Short-sellers might argue that UTI's growth is not translating into profitability, as operating income has declined significantly despite higher revenue. The spike in SBC could be masking true earnings, and if the company cannot control costs, the stock may be overvalued. Additionally, the volatile gross margins suggest potential operational inefficiencies that could persist.

UTI — Frequently Asked Questions

Quick answers to the most common questions about buying UTI stock.

What was Universal Technical Institute, Inc.'s (UTI) revenue in 2025?

For fiscal year 2025, Universal Technical Institute, Inc. (UTI) reported total revenue of $835.6M. This represents a 807.5% increase compared to $92.1M in 2000.

Is Universal Technical Institute, Inc. (UTI) profitable?

Universal Technical Institute, Inc. (UTI) is profitable, generating $63.0M in net income for the fiscal year ending 2025 with a net profit margin of 7.5%.

What is Universal Technical Institute, Inc.'s operating profit margin?

Universal Technical Institute, Inc. (UTI) reported an operating income of $83.5M, resulting in an operating profit margin of 10.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Universal Technical Institute, Inc.'s gross profit and gross margin?

Universal Technical Institute, Inc. (UTI) generated $415.1M in gross profit for the year, representing a gross profit margin of 49.7%. This demonstrates the company's core pricing power and production efficiency.